Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Celiac artery stenosis and cephalic duodenopancreatectomy: An undervalued risk?
Journal Information
Vol. 89. Issue 4.
Pages 230-236 (April 2011)
Share
Share
Download PDF
More article options
Vol. 89. Issue 4.
Pages 230-236 (April 2011)
Original article
Full text access
Celiac artery stenosis and cephalic duodenopancreatectomy: An undervalued risk?
La estenosis del tronco celiaco y duodenopancreatectomía cefálica: ¿un riesgo infravalorado?
Visits
1244
José Murosa, Jordi Sorianob, Antonio Codina-Barrerasc, Pere Planellasc, Santiago Lopez-Benc, Maite Albiolc, Laia Falguerasc, Ernesto Castroc, Anna Pigemc, Albert Marotod, Joan Figuerasc,*
a Servicio de Cirugía, Hospital de Getafe, Getafe, Madrid, Spain
b IDI, Hospital Josep Trueta de Girona, IdIBGi, Girona, Spain
c Servicio de Cirugía, Hospital Josep Trueta de Girona, IdIBGi, Girona, Spain
d Servicio de Radiología, Hospital Josep Trueta de Girona, IdIBGi, Girona, Spain
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract
Introduction

Significant celiac trunk or artery stenosis (CAS) is normally asymptomatic. However, when the arteries of the pancreatoduodenal arcade are occluded, it could trigger a visceral ischaemia. The objective of this study is to determine whether preoperative CAS is a risk factor for developing complications in patients subjected to duodenopancreatectomy (DPC).

Material and methods

We have retrospectively analysed 58 consecutive patients subjected to DPC. We have associated significant CAS with post-surgical outcome. In all cases a 16-channel multidetector computed tomography (MDCT) in three hepatic phases was performed. We have reviewed the pre-surgical MDCT focusing on the morphology of the celiac artery (CA), particularly in the presence or absence of significant stenosis (>50%).

Results

We found CAS >50% in 13 patients (22%). The overall mortality was 5% (3 patients). Serious complications developed in 16 (28%) patients, 8 (62%) of whom belonged to the group with significant CAS (P=.004). Ten patients (17%) had a pancreatic fistula, 5 (38%) vs 5 (11%) (P=.036); Fourteen patients (24%) needed new surgery, 7 (54%) vs 7 (16%) (P=.009); Seven patients (12%) had a haemoperitoneum, 4 (31%) vs 3 (7%) (P=.038), in the group with and without CAS, respectively.

Conclusions

Significant radiological CAS is a risk factor of serious complications after DPC. The study of the calibre of the superior mesenteric artery (SMA) with MDCT should be routine before a DPC. The correction of a significant CAS should be evaluated preoperatively..

Keywords:
Arterial stenosis
Celiac artery/trunk
Duodenopancreatectomy
Pancreatic cancer
Multidetector computed tomography
Surgery
Humans
Resumen
Introducción

La estenosis significativa del tronco celiaco habitualmente cursa de forma asintomática. No obstante, cuando se interrumpe la arcada de las arterias pancreatoduodenales, puede producirse isquemia visceral. El objetivo de este estudio es determinar si la estenosis preoperatoria del tronco celiaco es un factor de riesgo de complicaciones en pacientes sometidos a duodenopancreatectomía (DPC).

Material y métodos

Hemos analizado retrospectivamente a 58 pacientes consecutivos sometidos a DPC. Hemos relacionado la estenosis significativa del tronco celiaco con la evolución posquirúrgica. En todos los casos se ha realizado un estudio mediante tomografía computarizada multidetector (TCDM) de 16 canales en tres fases hepáticas. Hemos revisado la TCDM prequirúrgica centrándonos en la morfología del tronco celiaco, especialmente la presencia o ausencia de estenosis significativa (> 50%).

Resultados

Encontramos estenosis del tronco celiaco > 50% en 13 pacientes (22%). La mortalidad total fue de 3 pacientes (5%). La morbilidad total fue del 62%. En 16 pacientes (28%) hubo complicaciones graves, de los que 8 (62%) pertenecen al grupo de estenosis significativa del tronco celiaco (p=0,004); 10 pacientes (17%) presentaron fístula pancreática, 5 (38%) vs. 5 (11%) (p=0,036); 14 pacientes (24%) necesitaron reoperación, 7 (54%) vs. 7 (16%) (p=0,009); 7 pacientes (12%) presentaron hemoperitoneo, 4 (31%) vs. 3 (7%) (p=0,038), en los grupos con y sin estenosis del tronco celiaco respectivamente.

Conclusiones

La estenosis radiológicamente significativa del tronco celiaco es un factor de riesgo de complicaciones graves tras DPC. El estudio del calibre de la AMS con TCDM debería ser sistemático antes de una DPC. Debería valorarse preoperatoriamente la corrección de la estenosis significativa del tronco celiaco.

Palabras clave:
Estenosis arterial
Tronco celiaco
Duodenopancreatectomía
Cáncer de páncreas
Tomografía computarizada multidetector
Cirugía
Humanos
Full text is only aviable in PDF
References
[1.]
T. Berney, R. Pretre, G. Chassot, P. Morel.
The role of revascularization in celiac occlusion and pancreatoduodenectomy.
Am J Surg, 176 (1998), pp. 352-356
[2.]
D.E. Szilagyi, R.L. Rian, J.P. Elliot, R.F. Smith.
The celiac artery compression syndrome: does it exist?.
Surgery, 72 (1972), pp. 849-863
[3.]
C.M. Park, J.W. Chung, H.B. Kim, S.J. Shin, J.H. Park.
Celiac axis stenosis: incidence and etiologies in asymptomatic individuals.
Korean J Radiol, 2 (2001), pp. 8-13
[4.]
D.A. Bluemke, J.L. Cameron, R.H. Hruban, et al.
Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation.
Radiology, 197 (1995), pp. 381-385
[5.]
S. Gaujoux, A. Sauvanet, M.P. Vullierme, A. Cortes, S. Dokmak, A. Sibert, et al.
Ischemic complications after pancreaticoduodenectomy: incidence, prevention, and management.
Ann Surg, 249 (2009), pp. 111-117
[6.]
J. Figueras, A. Codina-Barreras, S. López-Ben, A. Maroto, S. Torres- Bahí, H.D. González, et al.
Cephalic duodenopancreatectomy in periampullary tumours. Dissection of the superior mesenteric artery as an initial approach. Description of the technique and an assessment of our initial experience.
Cir Esp, 83 (2008), pp. 186-193
[7.]
D. Dindo, N. Demartines, P.A. Clavien.
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.
Ann Surg, 240 (2004), pp. 205-213
[8.]
C. Bassi, C. Dervenis, G. Butturini, A. Fingerhut, C. Yeo, J. Izbicki, et al.
Postoperative pancreatic fistula: an international study group (ISGPF) definition.
[9.]
C.J. Yeo, J.L. Cameron, K.D. Lillemoe, J.V. Sitzmann, R.H. Hruban, S.N. Goodman, et al.
Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients.
Ann Surg, 221 (1995), pp. 721-731
[10.]
K.D. Lillemoe, C.J. Yeo, J.L. Cameron.
Pancreatic cancer: state-of-theart care.
CA Cancer J Clin, 50 (2000), pp. 241-268
[11.]
J.H Balcom, D.W. Rattner, A.L. Warshaw, Y. Chang, C. Fernandez-del Castillo.
Ten year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.
Arch Surg, 136 (2001), pp. 391-398
[12.]
M.W. Büchler, H. Friess, M. Wagner, C. Kulli, V. Wagener, K. Z’graggen.
Pancreatic fistula after pancreatic head resection: analysis of 331 consecutive patients.
[13.]
M. Trede, H.D. Saeger, G. Schwall, B. Rumstadt.
Resection of pancreatic cancer: surgical achievements.
Langenbecks Arch Surg, 383 (1998), pp. 121-128
[14.]
C.J. Yeo, J.L. Cameron, T.A. Sohn, et al.
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.
Ann Surg, 226 (1997), pp. 248-257
[15.]
J.L. Cameron, T.S. Riall, J. Coleman, et al.
One thousand consecutive pancreaticoduodenectomies.
[16.]
M.W. Buchler, M. Wagner, B.M. Schmied, et al.
Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy.
Arch Surg, 138 (2003), pp. 1310-1314
[17.]
F. Michelassi, F. Erroi, P.J. Dawson, A. Pietrabissa, S. Noda, M. Handcock, et al.
Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.
Ann Surg, 210 (1989), pp. 544-554
[18.]
K.K. Kazanjian, O.J. Hines, G. Eibl, H.A. Reber.
Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients.
Arch Surg, 140 (2005), pp. 849-854
[19.]
K.E. Bakkevold, B. Kambestad.
Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results.
Ann Surg, 217 (1993), pp. 356-368
[20.]
P.J. Shukla, S.G. Barreto, A. Kulkarni, G. Nagarajan, A. Fingerhut.
Vascular anomalies encountered during pancreatoduodenectomy: do they influence outcomes?.
Ann Surg Oncol, 17 (2010), pp. 186-193
[21.]
G.H. Sakorafas, M.G. Sarr, G. Peros.
Celiac artery stenosis: an underappreciated and unpleasant surprise in patients undergoing pancreaticoduodenectomy.
J Am Coll Surg., 206 (2008), pp. 349-356
[22.]
I. Kurosaki, K. Hatakeyama, K.E. Nihei, M. Oyamatsu.
Celiac axis stenosis in pancreaticoduodenectomy.
J Hepatobiliary Pancreat Surg, 11 (2004), pp. 119-124
[23.]
V.I. Egorov, N.I. Yashina, A.V. Fedorov, G.G. Karmazanovsky, V.A. Vishnevsky, T.V. Shevchenko.
Celiaco-mesenterial arterial aberrations in patients undergoing extended pancreatic resections: correlation of CT angiography with findings at surgery.
JOP, 11 (2010), pp. 348-357
[24.]
M.C. Machado, S. Penteado, A.L. Montagnini, M.A. Machado.
An alternative technique in the treatment of celiac axis stenosis diagnosed during pancreaticoduodenectomy.
HPB Surg, 10 (1998), pp. 371-373
[25.]
P.B. Mensink, A.S. Van Petersen, R.H. Geelkerken, J.A. Otte, A.B. Huisman, J.J. Kolkman.
Clinical significance of splanchnic artery stenosis.
Br J Surg, 93 (2006), pp. 1377-1382
[26.]
K.J. Hansen, D.B. Wilson, T.E. Craven, J.D. Pearce, W.P. English, M.S. Edwards, et al.
Mesenteric artery disease in the elderly.
J Vasc Surg, 40 (2004), pp. 45-52
[27.]
M.A. Makary, J.M. Winter, J.L. Cameron, K.A. Campbell, D. Chang, S.C. Cunningham, et al.
Pancreaticoduodenectomy in the very elderly.
J Gastrointest Surg, 10 (2006), pp. 347-356
Copyright © 2011. Asociación Española de Cirujanos
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.cireng.2024.02.001
No mostrar más